ad

Global Health Q4 FY26 Results: PAT of Rs 143.98 crore (up 41.97% YoY) Multi-Specialty Hospitals

15 May 20265:11 pm

Global Health Q4 FY26 Results: PAT of Rs 143.98 crore (up 41.97% YoY) Multi-Specialty Hospitals

Global Health Q4 results were announced on May 14, 2026, at the company's board meeting. Global Health Limited (Medanta Hospitals) Q4 FY26 PAT rose 41.97% YoY to Rs 143.98 crore from Rs 101.40 crore in Q4 FY25. FY26 total income Rs 4,157 crore (up from Rs 3,771 crore in FY25). FY26 PAT significantly higher than FY25's Rs 481.44 crore. Medanta operates hospitals in Gurugram, Lucknow, Patna, Ranchi, Indore, Noida, and Dubai, with 4,000+ beds and 35+ specialties. Investors tracking the company will find complete financial data, analysis, and FY27 outlook in this article.

Click Here – Get Free Investment Predictions

Global Health Q4 FY26 Key Financial Highlights

Metric Q4 FY26 Comparison
PAT (Net Profit) Rs 143.98 crore Q4 FY25 / Reference | up 41.97% YoY from Rs 101.40 crore
Ticker MEDANTA Sector: Multi-Specialty Hospitals

Screen the best stocks on the Univest Screener.

Global Health Performance Analysis

The company results reflect the company's operational performance during the January to March 2026 quarter. Global Health Limited (Medanta Hospitals) Q4 FY26 PAT rose 41.97% YoY to Rs 143.98 crore from Rs 101.40 crore in Q4 FY25. FY26 total income Rs 4,157 crore (up from Rs 3,771 crore in FY25) Investors and analysts monitoring the company results will focus on FY27 revenue guidance, margin trajectory, and management commentary on business outlook.

The company performance positions the company for FY27. Track the company analyst ratings and live stock price on the Univest Screener for real-time investment insights.

Global Health FY27 Outlook

Post Global, investor focus for FY27 will be on revenue growth momentum, margin expansion, new order wins, and sector-specific tailwinds in the Multi-Specialty Hospitals space. The Global results demonstrate the company's execution capabilities. Track Global updates on the Univest Screener for analyst views and FY27 earnings estimates.

Download the Univest iOS App or the Univest Android App to track live price and Q4 FY26 earnings updates.

Frequently Asked Questions on Global Health Q4 FY26 Results

What is Global Health Q4 FY26 PAT?

Ans. Global Health Q4 FY26 profit after tax was Rs 143.98 crore, up 41.97% YoY from Rs 101.40 crore in Q4 FY25..

When did Global Health announce Q4 FY26 results?

Ans. the company results were announced on May 14, 2026, at the company's board meeting and filed with BSE and NSE.

What is the FY27 outlook for Global Health?

Ans. Post the company results, investors will track FY27 guidance and growth strategies in the Multi-Specialty Hospitals sector. Track live updates on the Univest Screener.

Where can I track Global Health Q4 FY26 live data?

Ans. Track the company live stock price, analyst ratings, and earnings updates on the Univest Screener for real-time investment data.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered advisor before making any investment decision.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down